Rankings
▼
Calendar
PRTA Q3 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$970,000
-98.9% YoY
Gross Profit
$970,000
100.0% margin
Operating Income
-$67M
-6857.0% margin
Net Income
-$59M
-6082.6% margin
EPS (Diluted)
$-1.10
QoQ Revenue Growth
-99.3%
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$45M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$595M
Total Liabilities
$61M
Stockholders' Equity
$534M
Cash & Equivalents
$519M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$970,000
$85M
-98.9%
Gross Profit
$970,000
$27M
-96.4%
Operating Income
-$67M
$10M
-745.3%
Net Income
-$59M
$22M
-369.3%
Revenue Segments
Collaboration
$970,000
100%
← FY 2024
All Quarters
Q4 2024 →